3-Fluoro-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-ol, 95.0%, 250mg

2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline, 97%, 250mg

2-Chloro-4-fluorophenyl isothiocyanate, 97.0%, 5g

2-(3-Formyl-2-methyl-indol-1-yl)-acetamide, 95.0%, 5g

4-(2,3-dichlorophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

ETHYL 2-(PYRIDIN-4-YL)ISONICOTINATE, 95.0%, 250mg

LDN-22684>98.0%(HPLC)100mg

6-(cyclopentyloxy)nicotinic acid, 95.0%, 2.5g

N-(2-HYDROXY-6-NITROPHENYL)BUTYRAMIDE, 95.0%, 2g

Methyl 5-bromo-3-fluorothiophene-2-carboxylate, 98%, 500mg

5-Fluoro-2-methylbenzoxazole, 97.0%, 1g

4-Ethynyl-3-methylbenzoic acid, 97.0%, 1g

Colonne capillaire GC ROTI®Cap-1701, 30 m, 0,25 mm, 0,50 µm, 1 pièce(s)